Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13636 ◽

2018 ◽

Vol 84 (9) ◽

pp. 2029-2039 ◽

Author(s):

Wen-Hsuan Hou ◽

Kai-Cheng Chang ◽

Chung-Yi Li ◽

Huang-Tz Ou

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Risk Of Fracture ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Differential Cardiovascular Outcomes after Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Pioglitazone Therapy, All in Combination with Metformin, for Type 2 Diabetes: A Population-Based Cohort Study

PLoS ONE ◽

10.1371/journal.pone.0124287 ◽

2015 ◽

Vol 10 (5) ◽

pp. e0124287 ◽

Author(s):

Jong-Mi Seong ◽

Nam-Kyong Choi ◽

Ju-Young Shin ◽

Yoosoo Chang ◽

Ye-Jee Kim ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Cardiovascular Outcomes ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2020.108546 ◽

2021 ◽

Vol 171 ◽

pp. 108546

Author(s):

Chen-Yi Wu ◽

Chun-Ying Wu ◽

Chung-Pin Li ◽

Yiing-Jenq Chou ◽

Yi-Hsian Lin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Bullous Pemphigoid ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase‐4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population‐based cohort study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.13955 ◽

2019 ◽

Vol 85 (8) ◽

pp. 1719-1727 ◽

Author(s):

Jong‐Mi Seong ◽

Jeong Yee ◽

Hye Sun Gwak

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cohort Study ◽

Autoimmune Disease ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study

BMJ ◽

10.1136/bmj.k872 ◽

2018 ◽

pp. k872 ◽

Author(s):

Devin Abrahami ◽

Antonios Douros ◽

Hui Yin ◽

Oriana Hoi Yun Yu ◽

Christel Renoux ◽

...

Keyword(s):

Type 2 Diabetes ◽

Inflammatory Bowel Disease ◽

Cohort Study ◽

Bowel Disease ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Inflammatory Bowel

Download Full-text

Dipeptidyl peptidase‐4 inhibitors and risk of diabetic retinopathy progression in patients with type 2 diabetes: a population‐based cohort study

Acta Ophthalmologica ◽

10.1111/aos.13972_74 ◽

2018 ◽

Vol 96 (S261) ◽

pp. 23-23

Keyword(s):

Type 2 Diabetes ◽

Diabetic Retinopathy ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan

Cardiovascular Diabetology ◽

10.1186/s12933-017-0640-5 ◽

2017 ◽

Vol 16 (1) ◽

Author(s):

Chia-Yu Chang ◽

Yung-Hsin Yeh ◽

Yi-Hsin Chan ◽

Jia-Rou Liu ◽

Shang-Hung Chang ◽

...

Keyword(s):

Atrial Fibrillation ◽

Type 2 Diabetes ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study

Acta Diabetologica ◽

10.1007/s00592-020-01533-5 ◽

2020 ◽

Vol 57 (10) ◽

pp. 1181-1192

Author(s):

Yi-Chuan Chen ◽

Tien-Hsing Chen ◽

Chi-Chin Sun ◽

Jau-Yuan Chen ◽

Shy-Shin Chang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cohort Study ◽

Autoimmune Diseases ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-205216 ◽

2014 ◽

Vol 74 (11) ◽

pp. 1968-1975 ◽

Author(s):

Seoyoung C Kim ◽

Sebastian Schneeweiss ◽

Robert J Glynn ◽

Michael Doherty ◽

Allison B Goldfine ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Autoimmune Diseases ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors

Download Full-text

The dipeptidyl peptidase-4 inhibitor vildagliptin does not affect ex vivo cytokine response and lymphocyte function in patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2013.12.039 ◽

2014 ◽

Vol 103 (3) ◽

pp. 395-401 ◽

Author(s):

P.C.M. van Poppel ◽

M.S. Gresnigt ◽

P. Smits ◽

M.G. Netea ◽

C.J. Tack

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Ex Vivo ◽

Dipeptidyl Peptidase ◽

Cytokine Response ◽

Lymphocyte Function ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

Effect of dipeptidyl peptidase IV inhibitors, thiazolidinedione, and sulfonylurea on osteoporosis in patients with type 2 diabetes: population-based cohort study

Osteoporosis International ◽

10.1007/s00198-020-05801-6 ◽

2021 ◽

Author(s):

B. R. Yang ◽

S. H. Cha ◽

K. E. Lee ◽

J. W. Kim ◽

J. Lee ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Dipeptidyl Peptidase ◽

Population Based ◽

Dipeptidyl Peptidase Iv ◽

Dipeptidyl Peptidase Iv Inhibitors

Download Full-text